跳至主要内容
临床试验/NCT00326222
NCT00326222已完成不适用

Patient Education in NorthTrondelag Hospital Trust - Interventions, Effects and Patient Experience

Norwegian University of Science and Technology2 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2006年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
146
试验地点
2
主要终点
PAM - Patient activation measure

研究概览

简要总结

The purpose of this randomised open study is to examine the effect of self-management program for diabetes patients.

详细描述

The primary aim in this study is HbA1c in addition to secondary aims like quality of life and coping.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with ICPC-2, code T89 - diabetes dependent on insulin and T90 diabetes not dependent on insulin

排除标准

  • Diagnosed with ICPC-2, code T89 - diabetes mellitus juvenile and diabetes I
  • Attended self-management program previous 12 months

结局指标

主要结局

PAM - Patient activation measure

时间窗: Baseline, 6, and 12 mds

HbA1c

时间窗: Baseline, 6, and 12 mds

次要结局

  • SF36(Baseline, 6, and 12 mds)
  • EQ 5D-VAS scale(Baseline, 6, and 12 mds)
  • Hunt diabetes(Baseline, 6, and 12 mds)
  • Knowledge of diabetes(Baseline, 6, and 12 mds)
  • Cost/benefit(Baseline, 6, and 12 mds)
  • Triglyceride(Baseline, 6, and 12 mds)
  • WHO-DTSQ(Baseline, 6, and 12 mds)
  • HDL-cholesterol(Baseline, 6, and 12 mds)
  • Creatinin(Baseline, 6, and 12 mds)
  • Blood pressure(Baseline, 6, and 12 mds)
  • BMI(Baseline, 6, and 12 mds)
  • Total cholesterol(Baseline, 6, and 12 mds)
  • Weight(Baseline, 6, and 12 mds)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验